Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Leo Mascarenhas, MD

    TitleAssociate Professor of Clinical Pediatrics
    SchoolKeck School of Medicine of USC
    DepartmentPediatrics
    AddressCHL 4650 W Sunset Boulevard
    Off Campus
    Los Angeles California 90027
    Phone+1 323 361 2529
    Emaillmascarenhas@chla.usc.edu
    vCardDownload vCard
      Other Positions
      TitleSection Head, Oncology

      TitleDirector Solid Tumor Program

      TitleDirector of Clinical Trials office


      Collapse Overview 
      Collapse Overview
      Leo Mascarenhas, MD is director of the Clinical Trials Office in the Children’s Center for Cancer and Blood Diseases and Principal Investigator for the National Cancer Institute funded Children’s Oncology Group grant at Children’s Hospital Los Angeles. He is an associate professor of Clinical Pediatrics at the Keck School of Medicine of the University of Southern California.

      Childhood cancer is the leading cause of disease-related death in pediatrics in the United States. Dr. Mascarenhas and his team's research focuses on developmental therapeutics for patients with bone and soft tissue sarcomas. Despite the remarkable progress made in the treatment of childhood cancer in the last four decades, improved therapies are still needed for our patients with a poor prognosis and less toxic therapies for those destined to survive. This can be accomplished only through basic, translational and clinical research.


      Collapse ORNG Applications 
      Collapse Websites
      Collapse Featured Videos
      Collapse In The News

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Zhou S, Venkatramani R, Gupta S, Wang K, Wang L, Mascarenhas L. Hepatocellular Malignant Neoplasm-NOS: A Clinicopathologic Study of 11 Cases from a Single Institution. Histopathology. 2017 Jun 28. PMID: 28660626.
        View in: PubMed
      2. Landier W, Hageman L, Chen Y, Kornegay N, Evans WE, Bostrom BC, Casillas J, Dickens DS, Angiolillo AL, Lew G, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Relling MV, Wong FL, Bhatia S. Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1. J Clin Oncol. 2017 Mar 24; JCO2016717579. PMID: 28339328.
        View in: PubMed
      3. Landier W, Chen Y, Hageman L, Kim H, Bostrom BC, Casillas JN, Dickens DS, Evans WE, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Relling MV, Wong FL, Bhatia S. Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: A Children's Oncology Group study. Blood. 2017 Feb 02. PMID: 28153823.
        View in: PubMed
      4. Szymanski LJ, Molas-Torreblanca K, Bawab R, Kim E, Don D, Mascarenhas L, Stanley P, Zhou S, Shillingford N. Bronchial Mucoepidermoid Carcinoma With the Classic MAML2 Gene Rearrangement in a 2-year-old Boy. Pediatr Dev Pathol. 2017 Jan 01; 1093526617707855. PMID: 28492094.
        View in: PubMed
      5. Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KL, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PC, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MC, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncol. 2016 Oct; 17(10):1396-1408. PMID: 27569442.
        View in: PubMed
      6. Reed DR, Mascarenhas L, Manning K, Hale GA, Goldberg J, Gill J, Sandler E, Isakoff MS, Smith T, Caracciolo J, Lush RM, Juan TH, Lee JK, Neuger AM, Sullivan DM. Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies. Cancer Med. 2016 Feb; 5(2):294-303. PMID: 26714427.
        View in: PubMed
      7. Mascarenhas L, Felgenhauer JL, Bond MC, Villaluna D, Femino JD, Laack NN, Ranganathan S, Meyer J, Womer RB, Gorlick R, Krailo MD, Marina N. Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Mar; 63(3):493-8. PMID: 26579879.
        View in: PubMed
      8. De A, Mascarenhas L, Kamath S, LaRiviere A, Goodarzian F, Keens TG, Venkatramani R. Pilot Feasibility Study of Comprehensive Pulmonary Evaluation Following Lung Radiation Therapy. J Pediatr Hematol Oncol. 2015 Oct; 37(7):e412-8. PMID: 26241727.
        View in: PubMed
      9. Venkatramani R, Triche TJ, Wang L, Shimada H, Mascarenhas L. Insulin-like Growth Factor 2 Gene Expression Molecularly Differentiates Pleuropulmonary Blastoma and Embryonal Rhabdomyosarcoma. J Pediatr Hematol Oncol. 2015 Aug; 37(6):e356-60. PMID: 26056800.
        View in: PubMed
      10. Chien MC, Mascarenhas L, Hammoudeh JA, Venkatramani R. Zoledronic Acid for the Treatment of Children With Refractory Central Giant Cell Granuloma. J Pediatr Hematol Oncol. 2015 Aug; 37(6):e399-401. PMID: 26056788.
        View in: PubMed
      11. Bhatia S, Landier W, Hageman L, Chen Y, Kim H, Sun CL, Kornegay N, Evans WE, Angiolillo AL, Bostrom B, Casillas J, Lew G, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Wong FL, Relling MV. Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. JAMA Oncol. 2015 Jun 1; 1(3):287-95. PMID: 26181173.
        View in: PubMed
      12. Chan R, Mascarenhas L, Boles RG, Kerkar N, Genyk Y, Venkatramani R. Hepatoblastoma in a patient with methylmalonic aciduria. Am J Med Genet A. 2015 Mar; 167(3):635-8. PMID: 25691417.
        View in: PubMed
      13. HaDuong JH, Martin AA, Skapek SX, Mascarenhas L. Sarcomas. Pediatr Clin North Am. 2015 Feb; 62(1):179-200. PMID: 25435119.
        View in: PubMed
      14. Zhou S, Gomulia E, Mascarenhas L, Wang L. Is INI1-retained small cell undifferentiated histology in hepatoblastoma unfavorable? Hum Pathol. 2015 Jan 14. PMID: 25649007.
        View in: PubMed
      15. Tran HC, Marachelian A, Venkatramani R, Jubran RF, Mascarenhas L. Oxaliplatin and Doxorubicin for relapsed or refractory high-risk neuroblastoma. Pediatr Hematol Oncol. 2015 Feb; 32(1):26-31. PMID: 25551355.
        View in: PubMed
      16. Su A, Low L, Li X, Zhou S, Mascarenhas L, Barnhill RL. De novo congenital melanoma: analysis of 2 cases with array comparative genomic hybridization. Am J Dermatopathol. 2014 Nov; 36(11):915-9. PMID: 25051103.
        View in: PubMed
      17. Venkatramani R, Stein JE, Sapra A, Genyk Y, Jhaveri V, Malogolowkin M, Mascarenhas L. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. Br J Surg. 2015 Jan; 102(1):108-13. PMID: 25349947.
        View in: PubMed
      18. Venkatramani R, Mascarenhas L. Successful treatment of recurrent metastatic nasopharyngeal carcinoma with oxaliplatin and Doxorubicin. J Pediatr Hematol Oncol. 2014 Jul; 36(5):e307-9. PMID: 24276035.
        View in: PubMed
      19. Armenian SH, Gelehrter SK, Vase T, Venkatramani R, Landier W, Wilson KD, Herrera C, Reichman L, Menteer JD, Mascarenhas L, Freyer DR, Venkataraman K, Bhatia S. Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors. Clin Cancer Res. 2014 Dec 15; 20(24):6314-23. PMID: 24947931.
        View in: PubMed
      20. De A, Guryev I, LaRiviere A, Kato R, Wee CP, Mascarenhas L, Keens TG, Venkatramani R. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin. Pediatr Blood Cancer. 2014 Sep; 61(9):1679-84. PMID: 24789770.
        View in: PubMed
      21. Venkatramani R, Shoureshi P, Malvar J, Zhou S, Mascarenhas L. High dose alkylator therapy for extracranial malignant rhabdoid tumors in children. Pediatr Blood Cancer. 2014 Aug; 61(8):1357-61. PMID: 24789740.
        View in: PubMed
      22. Armenian SH, Gelehrter SK, Vase T, Venkatramani R, Landier W, Wilson KD, Herrera C, Reichman L, Menteer JD, Mascarenhas L, Freyer DR, Venkataraman K, Bhatia S. Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines. Cancer Epidemiol Biomarkers Prev. 2014 Jun; 23(6):1109-14. PMID: 24718281.
        View in: PubMed
      23. De A, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Mascarenhas L, Keens TG, Venkatramani R. Correlation of pulmonary function abnormalities with dose volume histograms in children treated with lung irradiation. Pediatr Pulmonol. 2015 Jun; 50(6):596-603. PMID: 24644268.
        View in: PubMed
      24. Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L. Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation. Pediatr Blood Cancer. 2014 Jul; 61(7):1277-81. PMID: 24482138.
        View in: PubMed
      25. Puliyel MM, Mascarenhas L, Zhou S, Sapra A, Dal Cin P, French CA, Venkatramani R. Nuclear protein in testis midline carcinoma misdiagnosed as adamantinoma. J Clin Oncol. 2014 May 20; 32(15):e57-60. PMID: 24470009.
        View in: PubMed
      26. Chan R, Mascarenhas L, Venkatramani R. Hepatoblastoma and hypoplastic kidneys: A new association. Pediatr Blood Cancer. 2014 Aug; 61(8):1476-8. PMID: 24623570.
        View in: PubMed
      27. Shah R, Tran HC, Randolph L, Mascarenhas L, Venkatramani R. Hepatoblastoma in a 15-month-old female with trisomy 13. Am J Med Genet A. 2014 Feb; 164(2):472-5. PMID: 24311532.
        View in: PubMed
      28. Venkatramani R, Malogolowkin MH, Mascarenhas L. Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab. Pediatr Blood Cancer. 2014 Apr; 61(4):756-9. PMID: 24115645.
        View in: PubMed
      29. Mehta B, Mascarenhas L, Zhou S, Wang L, Venkatramani R. Inflammatory myofibroblastic tumors in childhood. Pediatr Hematol Oncol. 2013 Oct; 30(7):640-5. PMID: 23988029.
        View in: PubMed
      30. Venkatramani R, Malogolowkin M, Davidson TB, May W, Sposto R, Mascarenhas L. A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. PLoS One. 2013; 8(7):e68416. PMID: 23894304.
        View in: PubMed
      31. Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L. Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation. Int J Radiat Oncol Biol Phys. 2013 Aug 1; 86(5):942-8. PMID: 23726005.
        View in: PubMed
      32. Arkader A, Myung KS, Stanley P, Mascarenhas L. Ewing sarcoma of the tibia mimicking fibrous dysplasia. J Pediatr Orthop B. 2013 May; 22(3):222-7. PMID: 22094991.
        View in: PubMed
      33. Ibrahim DA, Mascarenhas L, Tovar JP, Arkader A. Orthopaedic case of the month: A 14-year-old boy with a medial thigh soft tissue mass. Clin Orthop Relat Res. 2013 May; 471(5):1433-8. PMID: 23129475.
        View in: PubMed
      34. Mascarenhas L, Malogolowkin M, Armenian SH, Sposto R, Venkatramani R. A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors. Pediatr Blood Cancer. 2013 Jul; 60(7):1103-7. PMID: 23335436.
        View in: PubMed
      35. Venkatramani R, Malogolowkin MH, Wang L, Mascarenhas L. Pleuropulmonary Blastoma: A Single-institution Experience. J Pediatr Hematol Oncol. 2012 Jul; 34(5):e182-5. PMID: 22584785.
        View in: PubMed
      36. Bhatia S, Landier W, Shangguan M, Hageman L, Schaible AN, Carter AR, Hanby CL, Leisenring W, Yasui Y, Kornegay NM, Mascarenhas L, Ritchey AK, Casillas JN, Dickens DS, Meza J, Carroll WL, Relling MV, Wong FL. Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group. J Clin Oncol. 2012 Jun 10; 30(17):2094-101. PMID: 22564992.
        View in: PubMed
      37. Venkatramani R, Wang L, Malvar J, Dias D, Sposto R, Malogolowkin MH, Mascarenhas L. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma. Pediatr Blood Cancer. 2012 Sep; 59(3):493-8. PMID: 22190448.
        View in: PubMed
      38. Venkatramani R, Olch AJ, Mascarenhas L, Yoon S, Suterwala B, Mehta B, Wong K. Correlation of long-term pulmonary injury with radiation dose distribution in childhood cancer survivors. Pract Radiat Oncol. 2012 Jul-Sep; 2(3):237-40. PMID: 24674127.
        View in: PubMed
      39. Hingorani P, Seidel K, Krailo M, Mascarenhas L, Meyers P, Marina N, Conrad EU, Hawkins DS. Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011 Dec 1; 57(6):939-42. PMID: 21480474.
        View in: PubMed
      40. Mascarenhas L, Bond MC, Seibel NL. Expanded Access Through Cancer Trials Support Unit to Children's Oncology Group Sarcoma Trial AEWS1031 for Adolescents and Young Adults. J Adolesc Young Adult Oncol. 2011 Mar; 1(1):61-3. PMID: 26812570.
        View in: PubMed
      41. Venkatramani R, Ma NS, Pitukcheewanont P, Malogolowkin MH, Mascarenhas L. Gorham's disease and diffuse lymphangiomatosis in children and adolescents. Pediatr Blood Cancer. 2011 Apr; 56(4):667-70. PMID: 21298758.
        View in: PubMed
      42. Mascarenhas L, Lyden ER, Breitfeld PP, Walterhouse DO, Donaldson SS, Paidas CN, Parham DM, Anderson JR, Meyer WH, Hawkins DS. Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2010 Oct 20; 28(30):4658-63. PMID: 20837952.
        View in: PubMed
      43. Rovelo MO, Kim R, Mascarenhas L, Hammoudeh J, Urata MM. Recurrent and refractory giant cell tumor of the jaw. J Craniofac Surg. 2009 Nov; 20(6):2245-8. PMID: 19934683.
        View in: PubMed
      44. Imran H, Enders F, Krailo M, Sim F, Okuno S, Hawkins D, Neglia J, Randall RL, Womer R, Mascarenhas L, Arndt CA. Effect of time to resumption of chemotherapy after definitive surgery on prognosis for non-metastatic osteosarcoma. J Bone Joint Surg Am. 2009 Mar 1; 91(3):604-12. PMID: 19255220.
        View in: PubMed
      45. Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Brown K, Tarbell N, Bernstein ML, Granowetter L, Gebhardt M, Grier HE. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2008 Sep; 51(3):334-8. PMID: 18506764.
        View in: PubMed
      46. Armenian SH, Hoffman JA, Butturini AM, Kapoor N, Mascarenhas L. Invasive diagnostic procedures for pulmonary infiltrates in pediatric hematopoietic stem cell transplant recipients. Pediatr Transplant. 2007 Nov; 11(7):736-42. PMID: 17910650.
        View in: PubMed
      47. Madigan CE, Armenian SH, Malogolowkin MH, Mascarenhas L. Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience. Cancer. 2007 Nov 1; 110(9):2061-6. PMID: 17828773.
        View in: PubMed
      48. Harned TM, Mascarenhas L. Severe methotrexate toxicity precipitated by intravenous radiographic contrast. J Pediatr Hematol Oncol. 2007 Jul; 29(7):496-9. PMID: 17609630.
        View in: PubMed
      49. Yoon JM, Burns RC, Malogolowkin MH, Mascarenhas L. Treatment of infantile choriocarcinoma of the liver. Pediatr Blood Cancer. 2007 Jul; 49(1):99-102. PMID: 16206190.
        View in: PubMed
      50. Armenian SH, La Via WV, Siegel SE, Mascarenhas L. Evaluation of persistent pulmonary infiltrates in pediatric oncology patients. Pediatr Blood Cancer. 2007 Feb; 48(2):165-72. PMID: 16411212.
        View in: PubMed
      51. Wu SQ, Loh KT, Chen XR, Joo WJ, Mascarenhas L. Transient myeloproliferative disorder in a phenotypically normal infant with i(21q) mosaicism. Cancer Genet Cytogenet. 2002 Jul 15; 136(2):138-40. PMID: 12237238.
        View in: PubMed
      52. Stripecke R, Cardoso AA, Pepper KA, Skelton DC, Yu XJ, Mascarenhas L, Weinberg KI, Nadler LM, Kohn DB. Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage- colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses. Blood. 2000 Aug 15; 96(4):1317-26. PMID: 10942373.
        View in: PubMed
      53. Mascarenhas L, Stripecke R, Case SS, Xu D, Weinberg KI, Kohn DB. Gene delivery to human B-precursor acute lymphoblastic leukemia cells. Blood. 1998 Nov 15; 92(10):3537-45. PMID: 9808545.
        View in: PubMed